Late stage glaucoma is associated with considerable health and social care costs and a lower visual acuity (VA) is also predictive of a lower quality of life, according to John Thygesen from University Hospital Copenhagen, Denmark and colleagues from France, the UK and Germany.
Late stage glaucoma is associated with considerable health and social care costs and a lower visual acuity (VA) is also predictive of a lower quality of life, according to John Thygesen from University Hospital Copenhagen, Denmark and colleagues from France, the UK and Germany.
In order to estimate the societal costs and quality of life among patients with late stage primary open angle glaucoma (POAG), the charts of 162 such patients from Germany, France, the UK and Denmark were reviewed and patients interviewed.
Mean VA was 0.28 and 0.11 in the best and worst eye, respectively. Annual health maintenance costs were 830, excluding costs of surgery, whilst costs of devices and of home care averaged 2,045 and 2,703 per patient per year, respectively. The average quality of life score was 0.67 and the best predictor of quality of life was found to be visual acuity in the patient's best eye.
The study clearly demonstrates that late stage glaucoma is associated with considerable health and social care costs.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.